Abstract
Results from recent basic and clinical research investigations have greatly improved our understanding of insulin resistance in general and insulin resistance associated with PCOS in particular. With this understanding has come the possibility of using new methods to treat PCOS. This is particularly true when discussing the use of insulin-sensitizing drugs. Caution must be exercised in using these drugs be cause of unforeseen acute or remote adverse side effects. Postulated relationships among PCOS, hyperandrogenism, and insulin resistance do not completely solve the endocrinologic mystery of the patient with PCOS. For example, how does the partial destruction of the ovary (eg, wedge biopsy or ovary drilling by laser or cautery), which does not affect insulin resistance [58], result in ovulatory cycles? Why does the administration of excessive exogenous insulin in the case of the insulin-dependent diabetic fail to cause hyperandrogenism? Certainly, much remains to be learned about the reproductive endocrine disturbance we now call PCOS.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 517-527 |
| Number of pages | 11 |
| Journal | Infertility and Reproductive Medicine Clinics of North America |
| Volume | 14 |
| Issue number | 4 |
| State | Published - Oct 2003 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Polycystic ovary syndrome, hyperandrogenism, and insulin resistance. / Zacur, Howard A.
In: Infertility and Reproductive Medicine Clinics of North America, Vol. 14, No. 4, 10.2003, p. 517-527.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Polycystic ovary syndrome, hyperandrogenism, and insulin resistance
AU - Zacur, Howard A
PY - 2003/10
Y1 - 2003/10
N2 - Results from recent basic and clinical research investigations have greatly improved our understanding of insulin resistance in general and insulin resistance associated with PCOS in particular. With this understanding has come the possibility of using new methods to treat PCOS. This is particularly true when discussing the use of insulin-sensitizing drugs. Caution must be exercised in using these drugs be cause of unforeseen acute or remote adverse side effects. Postulated relationships among PCOS, hyperandrogenism, and insulin resistance do not completely solve the endocrinologic mystery of the patient with PCOS. For example, how does the partial destruction of the ovary (eg, wedge biopsy or ovary drilling by laser or cautery), which does not affect insulin resistance [58], result in ovulatory cycles? Why does the administration of excessive exogenous insulin in the case of the insulin-dependent diabetic fail to cause hyperandrogenism? Certainly, much remains to be learned about the reproductive endocrine disturbance we now call PCOS.
AB - Results from recent basic and clinical research investigations have greatly improved our understanding of insulin resistance in general and insulin resistance associated with PCOS in particular. With this understanding has come the possibility of using new methods to treat PCOS. This is particularly true when discussing the use of insulin-sensitizing drugs. Caution must be exercised in using these drugs be cause of unforeseen acute or remote adverse side effects. Postulated relationships among PCOS, hyperandrogenism, and insulin resistance do not completely solve the endocrinologic mystery of the patient with PCOS. For example, how does the partial destruction of the ovary (eg, wedge biopsy or ovary drilling by laser or cautery), which does not affect insulin resistance [58], result in ovulatory cycles? Why does the administration of excessive exogenous insulin in the case of the insulin-dependent diabetic fail to cause hyperandrogenism? Certainly, much remains to be learned about the reproductive endocrine disturbance we now call PCOS.
UR - http://www.scopus.com/inward/record.url?scp=0242362659&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242362659&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0242362659
VL - 14
SP - 517
EP - 527
JO - Infertility and Reproductive Medicine Clinics of North America
JF - Infertility and Reproductive Medicine Clinics of North America
SN - 1047-9422
IS - 4
ER -